Post-COVID-19 Myoclonus-Ataxia Syndrome-Is there Really a Need for Intravenous Immunoglobulin Treatment in all Cases?

Filip Przytuła¹, Jarosław Sławek^{1

2}

Affiliations

¹ Department of Neurology and Stroke St. Adalbert Hospital Gdańsk Poland.
² Department of Psychiatric and Neurological Nursing, Division of Health Sciences Medical University of Gdańsk Gdańsk Poland.

Filip Przytuła et al. Mov Disord Clin Pract. 2023.

. 2023 Mar 25;10(4):724-725.

doi: 10.1002/mdc3.13695. eCollection 2023 Apr.

Filip Przytuła¹, Jarosław Sławek^{1

2}

¹ Department of Neurology and Stroke St. Adalbert Hospital Gdańsk Poland.
² Department of Psychiatric and Neurological Nursing, Division of Health Sciences Medical University of Gdańsk Gdańsk Poland.

No abstract available

Keywords: COVID‐19; SARS CoV‐2; ataxia; myoclonus.

Cited by

Reply: Post-COVID-19 Myoclonus-Ataxia Syndrome-Is there Really a Need for Intravenous Immunoglobulin Treatment in all Cases?
Godani M, Beronio A, Lanza G. Godani M, et al. Mov Disord Clin Pract. 2023 Mar 25;10(4):726-727. doi: 10.1002/mdc3.13693. eCollection 2023 Apr. Mov Disord Clin Pract. 2023. PMID: 37070033 Free PMC article. No abstract available.

1. Godani M, Beronio A, Lanza G. Post‐COVID‐19 myoclonus‐ataxia syndrome responsive to intravenous immunoglobulins. Mov Disord Clin Pract 2022;9(Suppl 2):S6–S8. - PMC - PubMed
1. Sawczyńska K, Wężyk K, Bosak M, et al. Acute‐onset chorea and confusional state in 77‐year‐old COVID‐19 patient: a case report. Neurol Neurochir Pol 2022;56(1):106–110. - PubMed
1. Hirschfeld AS. Autoimmune mediated hyperkinetic movement disorders in SARS‐CoV‐2 infection—a systematic review. Neurol Neurochir Pol 2021;55(6):549–558. - PubMed
1. Schneider SA, Hennig A, Martino D. Relationship between COVID‐19 and movement disorders: a narrative review. Eur J Neurol 2022;29(4):1243–1253. - PubMed
1. Przytuła F, Błądek S, Sławek J. Two COVID‐19‐related video‐accompanied cases of severe ataxia‐myoclonus syndrome. Neurol Neurochir Pol 2021;55(3):310–313. - PubMed